<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mimedx Group Inc — News on 6ix</title>
<link>https://6ix.com/company/mimedx-group-inc</link>
<description>Latest news and press releases for Mimedx Group Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/mimedx-group-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835974f78dffbe2df104ee1.webp</url>
<title>Mimedx Group Inc</title>
<link>https://6ix.com/company/mimedx-group-inc</link>
</image>
<item>
<title>MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29</guid>
<pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
<description>MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day. The conference call can be accessed using the following information: We</description>
</item>
<item>
<title>MIMEDX Announces Restructuring and Cost Reduction Initiative</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-restructuring-and-cost-reduction-initiative</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-restructuring-and-cost-reduction-initiative</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>Company Expects to Realize Annualized Savings of Approximately $40 Million MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG)</description>
</item>
<item>
<title>MIMEDX to Sponsor Leading Advanced Wound Care Conferences</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-to-sponsor-leading-advanced-wound-care-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-to-sponsor-leading-advanced-wound-care-conferences</guid>
<pubDate>Thu, 02 Apr 2026 13:15:00 GMT</pubDate>
<description>Multispecialty Focus with Industry Leadership Aimed at Improving Patient Outcomes Company Will Feature Recent Additions to Its Advanced Wound Care Portfolio MARIETTA, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its participation in two leading wound care conferences: the Symposium on Advanced Wound Care (“SAWC”) Spring 2026 and MedStar Georgetown University Hospital’s Diabetic Limb Salvage (“DLS”) Conference. Through scien</description>
</item>
<item>
<title>MIMEDX Announces Launch of CHORIOFIX™</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-launch-of-choriofixtm</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-launch-of-choriofixtm</guid>
<pubDate>Mon, 23 Mar 2026 04:00:00 GMT</pubDate>
<description>Further Expands Company’s Broad Portfolio of Advanced Wound Care (“AWC”) Products MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc.</description>
</item>
<item>
<title>MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-expands-surgical-product-portfolio-with-the-launch-of-amniofixr-thyroid-shields-8</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-expands-surgical-product-portfolio-with-the-launch-of-amniofixr-thyroid-shields-8</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>Bolsters Surgical offering with product specifically designed for use in endocrine procedures MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group,</description>
</item>
<item>
<title>MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-record-fourth-quarter-and-full-year-2025-operating-and-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-record-fourth-quarter-and-full-year-2025-operating-and-financial-results</guid>
<pubDate>Wed, 25 Feb 2026 21:01:00 GMT</pubDate>
<description>Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted EBITDA1 was $29 Million, or 25% of Net Sales Company Estimates 2026 Net Sales in a Range of $340-360 Million Announces $100 Million Share Repurchase Program Authorization Management to Host Conference Call Today, February 25, 2026, at 4:30 PM ET MARIETTA, Ga., Feb. 25, 2026 (GLOBE NEWSWIRE) -- MiM</description>
</item>
<item>
<title>MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-to-host-fourth-quarter-and-full-year-2025-operating-and-financial-results-conference-call-on-february-25</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-to-host-fourth-quarter-and-full-year-2025-operating-and-financial-results-conference-call-on-february-25</guid>
<pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
<description>MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day. The conference call can be accessed using the follo</description>
</item>
<item>
<title>MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-enters-exclusive-distribution-agreement-152700149</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-enters-exclusive-distribution-agreement-152700149</guid>
<pubDate>Wed, 04 Feb 2026 15:27:00 GMT</pubDate>
<description>Agreement expands offering to include additional sheet, particulate and flowable productsMARIETTA, Ga., Feb. 04, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it has entered into an exclusive agreement with Summit Products Group (“Summit”) to distribute three innovative, 510(k) cleared products that complement the Company’s leading Surgical & Wound product portfolio: Hydrelix, NovaForm®, and G4Derm® Plus. About the products: Hydrelix Colla</description>
</item>
<item>
<title>MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-celebrates-15-year-anniversary-epifixr-and-amniofixr-2026-02-02</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-celebrates-15-year-anniversary-epifixr-and-amniofixr-2026-02-02</guid>
<pubDate>Mon, 02 Feb 2026 05:00:00 GMT</pubDate>
<description>Industry’s Most Studied Placental Allografts Appear in Nearly 100 Clinical and Scientific Publications MARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx</description>
</item>
<item>
<title>MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-enters-exclusive-us-distribution-agreement-regenkitr-wound-gel-2025-12-22</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-enters-exclusive-us-distribution-agreement-regenkitr-wound-gel-2025-12-22</guid>
<pubDate>Mon, 22 Dec 2025 05:00:00 GMT</pubDate>
<description>Company Continues to Broaden Leading Wound Product Offering MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or</description>
</item>
<item>
<title>MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-publication-journal-inflammation-focused-immunomodulatory-effects</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-publication-journal-inflammation-focused-immunomodulatory-effects</guid>
<pubDate>Fri, 19 Dec 2025 05:00:00 GMT</pubDate>
<description>Study investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair MARIETTA,</description>
</item>
<item>
<title>MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-provides-update-epieffectr-randomized-controlled-trial-2025-11-13</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-provides-update-epieffectr-randomized-controlled-trial-2025-11-13</guid>
<pubDate>Thu, 13 Nov 2025 05:00:00 GMT</pubDate>
<description>Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When Compared to</description>
</item>
<item>
<title>MIMEDX to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-participate-upcoming-investor-conferences-2025-11-10</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-participate-upcoming-investor-conferences-2025-11-10</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>MARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior</description>
</item>
<item>
<title>MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-comments-cy-2026-medicare-physician-fee-schedule-final-rule-2025-11-03</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-comments-cy-2026-medicare-physician-fee-schedule-final-rule-2025-11-03</guid>
<pubDate>Mon, 03 Nov 2025 05:00:00 GMT</pubDate>
<description>Company is Well Positioned to Continue to Compete and Grow MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the</description>
</item>
<item>
<title>MIMEDX Announces Record Revenue for Third Quarter 2025</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-record-revenue-third-quarter-2025-2025-10-29</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-record-revenue-third-quarter-2025-2025-10-29</guid>
<pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
<description>Second Consecutive Quarter of Highest Quarterly Net Sales in MIMEDX History Third Quarter Net Sales of $114 million Grew 35% Year-Over-Year Third Quarter GAAP</description>
</item>
<item>
<title>MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-host-third-quarter-2025-operating-and-financial-results-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-host-third-quarter-2025-operating-and-financial-results-conference-call</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>MARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its</description>
</item>
<item>
<title>MIMEDX Announces Launch of EPIXPRESS®</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-launch-epixpressr-2025-10-06</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-launch-epixpressr-2025-10-06</guid>
<pubDate>Mon, 06 Oct 2025 04:00:00 GMT</pubDate>
<description>Next-Generation, Lyophilized Human Placental Allograft Further Expands Company’s Broad Portfolio of Advanced Wound Care (“AWC”) Products MARIETTA, Ga., Oct.</description>
</item>
<item>
<title>MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-sponsor-and-attend-symposium-advanced-wound-care-sawc-fall-2025-09-03</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-sponsor-and-attend-symposium-advanced-wound-care-sawc-fall-2025-09-03</guid>
<pubDate>Wed, 03 Sep 2025 04:00:00 GMT</pubDate>
<description>To Present Six Posters Featuring the Company’s Latest Product Innovations MARIETTA, Ga., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG)</description>
</item>
<item>
<title>MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-record-second-quarter-2025-operating-and-financial-results-2025-07</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-record-second-quarter-2025-operating-and-financial-results-2025-07</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted</description>
</item>
<item>
<title>MIMEDX Announces Strategic Collaboration with Vaporox, Inc.</title>
<link>https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-strategic-collaboration-vaporox-inc-2025-07-30</link>
<guid isPermaLink="true">https://6ix.com/company/mimedx-group-inc/news/mimedx-announces-strategic-collaboration-vaporox-inc-2025-07-30</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>Relationship Establishes Co-Promotion and Co-Marketing of MIMEDX’s Leading Placental Allograft Portfolio and Vaporox’s Vaporous Hyperoxia Treatment Device</description>
</item>
</channel>
</rss>